Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors.

Conclusion: In this review, the most current and promising studies involving Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as oral drug carriers are reported aiming to assist researchers who focus their research on lipid based nanoparticles. PMID: 32753006 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32753006?dopt=Abstract

Source: Current Pharmaceutical Biotechnology - August 3, 2020 Category: Biotechnology Authors: Okur NÜ, Siafaka PI, Gökçe EH Tags: Curr Pharm Biotechnol Source Type: research